Evidence map›Paper›PMID 26769967›Full record

ArticleThe Journal of biological chemistry2016

Protein Kinase Cα (PKCα) Is Resistant to Long Term Desensitization/Down-regulation by Prolonged Diacylglycerol Stimulation.

Michelle A Lum, Carter J Barger, Alice H Hsu, Olga V Leontieva, Adrian R Black, Jennifer D Black

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The complexities of PKCα signaling in cancer.Advances in biological regulation · 2021
    Review
  5. Article
  6. Protein kinase C: perfectly balanced.Critical reviews in biochemistry and molecular biology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Michelle A LumFrom the Eppley Institute for Research in Cancer and Allied Diseases and the Fred and Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska 68198-5950 and the Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York 14263.
Carter J BargerFrom the Eppley Institute for Research in Cancer and Allied Diseases and the Fred and Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska 68198-5950 and.
Alice H HsuFrom the Eppley Institute for Research in Cancer and Allied Diseases and the Fred and Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska 68198-5950 and.
Olga V Leontievathe Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York 14263.
Adrian R BlackFrom the Eppley Institute for Research in Cancer and Allied Diseases and the Fred and Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska 68198-5950 and the Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York 14263.
Jennifer D BlackFrom the Eppley Institute for Research in Cancer and Allied Diseases and the Fred and Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska 68198-5950 and the Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York 14263 jennifer.black@unmc.edu.
University of Nebraska Medical Center · USRoswell Park Comprehensive Cancer Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dean G. Tang · 1985 to 2026
$116.6M
UNMC/EPPLEY CANCER CENTER SUPPORT GRANTP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Joann B. Sweasy · 1985 to 2026
$55.0M
CHEMICAL CARCINOGENESIS &CANCER BIOLOGYT32CA009476 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Jennifer D. Black · 1988 to 2026
$6.2M
REGULATION OF CYCLIN D1 EXPRESSION IN THE INTESTINER01DK060632 · NIDDK · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BLACK, JENNIFER D. · 2002 to 2014
$2.6M
PKC ISOZYMES AND INTESTINAL EPITHELIAL GROWTH CONTROLR01DK054909 · NIDDK · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BLACK, JENNIFER D. · 1999 to 2009
$2.1M
Regulation of cyclin D1 expression in the intestineR56DK060632 · NIDDK · ROSWELL PARK CANCER INSTITUTE CORP · PI BLACK, JENNIFER D. · 2009 to 2009
$373k
Evaluating the PKC Enzyme System in Human Colon CancerR21CA191894 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BLACK, JENNIFER D. · 2015 to 2016
$360k
NCI NIH HHS CA016056NCI NIH HHS CA036727NCI NIH HHS CA191894NCI NIH HHS P30 CA016056NCI NIH HHS P30 CA036727NCI NIH HHS R21 CA191894NCI NIH HHS T32 CA009476NIDDK NIH HHS DK054909NIDDK NIH HHS DK060632NIDDK NIH HHS R01 DK054909NIDDK NIH HHS R01 DK060632NIDDK NIH HHS R56 DK060632
6 · The paper itself

Abstract

Sustained activation of PKCα is required for long term physiological responses, such as growth arrest and differentiation. However, studies with pharmacological agonists (e.g. phorbol 12-myristate 13-acetate (PMA)) indicate that prolonged stimulation leads to PKCα desensitization via dephosphorylation and/or degradation. The current study analyzed effects of chronic stimulation with the physiological agonist diacylglycerol. Repeated addition of 1,2-dioctanoyl-sn-glycerol (DiC8) resulted in sustained plasma membrane association of PKCα in a pattern comparable with that induced by PMA. However, although PMA potently down-regulated PKCα, prolonged activation by DiC8 failed to engage known desensitization mechanisms, with the enzyme remaining membrane-associated and able to support sustained downstream signaling. DiC8-activated PKCα did not undergo dephosphorylation, ubiquitination, or internalization, early events in PKCα desensitization. Although DiC8 efficiently down-regulated novel PKCs PKCδ and PKCϵ, differences in Ca(2+) sensitivity and diacylglycerol affinity were excluded as mediators of the selective resistance of PKCα. Roles for Hsp/Hsc70 and Hsp90 were also excluded. PMA, but not DiC8, targeted PKCα to detergent-resistant membranes, and disruption of these domains with cholesterol-binding agents demonstrated a role for differential membrane compartmentalization in selective agonist-induced degradation. Chronic DiC8 treatment failed to desensitize PKCα in several cell types and did not affect PKCβI; thus, conventional PKCs appear generally insensitive to desensitization by sustained diacylglycerol stimulation. Consistent with this conclusion, prolonged (several-day) membrane association/activation of PKCα is seen in self-renewing epithelium of the intestine, cervix, and skin. PKCα deficiency affects gene expression, differentiation, and tumorigenesis in these tissues, highlighting the importance of mechanisms that protect PKCα from desensitization in vivo.

Indexed as

AnimalsCell Line, TumorDiglyceridesDown-RegulationEnzyme ActivationHumansIntestinal MucosaMembrane MicrodomainsProtein Kinase C-alphaProtein TransportProteolysisRatsSignal TransductionTetradecanoylphorbol Acetate1,2-dioctanoylglycerolDiglyceridesPRKCA protein, humanProtein Kinase C-alphaTetradecanoylphorbol Acetate70-kilodalton heat shock protein (Hsp70)diacylglycerolheat shock protein 90 (Hsp90)lipid raftPKCα, desensitizationprotein degradationprotein kinase C (PKC)protein phosphorylationsignal transduction

Identifiers

PMID26769967
PMCPMC4813581
OpenAlexW2332209807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.